Sign In
Buy SNY
$44.38
+2.01 (+4.74%)
At Close: Jun 04, 2026
Can Sanofi (SNY) Keep the Beat Streak Alive in Q4 Earnings?
08:45am, Tuesday, 31'st Jan 2023
Sanofi's (SNY) top line is likely to have been driven by higher sales of Dupixent and vaccines.
Top 5 Nasdaq Composite Stocks to Buy Ahead of Q4 Earnings
08:00am, Tuesday, 31'st Jan 2023
Five Nasdaq Composite companies are set to beat earnings estimates. These are: EXPE, IDXX, SNY, TW and SEDG.
2 Medical Stocks to Consider Buying Before Earnings
05:19pm, Monday, 30'th Jan 2023
There is a continued need for prosperous healthcare companies, here are two medical stocks investors may want to consider buying ahead of earnings this week.
U.S. Appeals Court Sides With Drugmakers on Discount Program
02:38pm, Monday, 30'th Jan 2023
The court ruled that drugmakers can limit their shipments of federally-discounted drugs to pharmacies, in a blow to hospitals and clinics.
Could This Vaccine Become Sanofi's Latest Blockbuster?
08:45am, Sunday, 29'th Jan 2023
This vaccine candidate could be approved in newborns and infants later this year.
Regeneron, Sanofi's Dupixent is one step closer to approval for young children in Europe
08:27am, Friday, 27'th Jan 2023
Shares of Regeneron Pharmaceuticals Inc. REGN, +0.15% gained about 2.5% in premarket trading on Friday after the European Medicines Agency's Committee for Medicinal Products for Human Use recommended
Mergers and Acquisitions in 2023 Off To A Strong Start
08:17am, Friday, 27'th Jan 2023
Mergers and acquisitions are a normal part of business, but 2023 has already presented many opportunities across the biotech industry. The M&A surge seems to be driven by two major transactions: the $
7 Blue-Chip Stocks to Buy as a New Bull Market Emerges
05:47pm, Thursday, 26'th Jan 2023
Buying blue-chip stocks is generally a smart decision. They tend to be established, profitable, name-brand companies marked by reliable growth.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:32am, Wednesday, 25'th Jan 2023
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
5 Value Stocks With Exciting EV-to-EBITDA Ratios to Own Now
07:32am, Wednesday, 25'th Jan 2023
We have screened value stocks NMM, HPE, AEG, COWN and SNY based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.
Sanofi CEO: Real breakthrough in RSV treatment is 'right around the corner'
08:37am, Thursday, 19'th Jan 2023
Paul Hudson, Sanofi CEO, joins 'Squawk Box' to discuss the company's product pipeline, Hudson's take on the trust the public have for vaccines and more.
SNY vs. NVO: Which Stock Is the Better Value Option?
12:47pm, Monday, 16'th Jan 2023
SNY vs. NVO: Which Stock Is the Better Value Option?
State of California Sues Insulin Makers for Unfair Practices
12:48pm, Friday, 13'th Jan 2023
The lawsuit aims to curb the skyrocketing cost of insulin charged by insulin manufacturers and pharmacy benefit managers companies. The State also seeks to recover some monetary compensation.
Sanofi SA (SNY) CEO Paul Hudson Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)
05:38pm, Tuesday, 10'th Jan 2023
Sanofi SA (NASDAQ:SNY ) 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 1:30 PM ET Company Participants Paul Hudson - CEO Conference Call Participants Richard Vosser - JPMorgan Richard
Ranking The Top 10 Pharmaceuticals By Pipeline
11:44pm, Monday, 09'th Jan 2023
The pipeline is the heart of a drug discovery company. As such, analyzing the health of a pipeline can lead to suggestions about future performance.
